Tramazoline 0.118% AFP Uses, Dosage, Side Effects and more
Tramazoline 0.118% AFP is under investigation in clinical trial NCT01601509 (Nasal Tramazoline 0.118% AFP and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline 0.118% AFP and).
| Attribute | Details |
|---|---|
| Trade Name | Tramazoline 0.118% AFP |
| Generic | Tramazoline |
| Tramazoline Other Names | Tramazolina, Tramazoline |
| Type | |
| Formula | C13H17N3 |
| Weight | Average: 215.3 Monoisotopic: 215.142247559 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Japan |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Tramazoline 0.118% AFP is a sympathomimetic indicated for nasal decongestion.
Tramazoline 0.118% AFP is also used to associated treatment for these conditions: Nasal Congestion
